Skip to main content
. 2022 Jan 14;6(5):nzac001. doi: 10.1093/cdn/nzac001

TABLE 1.

Description of PICOS (Population, Intervention, Comparison, Outcome, Study design) criteria for the research question, “What is the relationship between dietary patterns and risk of sarcopenia?”

Parameter Eligibility criteria
Population Human subjects ≥19 y at time of outcome who were healthy and/or at risk for chronic disease, not pregnant or lactating, living in countries ranked as high or higher human development1
Study populations composed of a mixed population of healthy, at risk, and diseased subjects, but not exclusively diagnosed with a disease or with low skeletal muscle mass, low muscle strength, low muscle performance, or sarcopenia were included
Intervention Consumption of and/or adherence to a dietary pattern (measured as an index/score; factor or cluster analysis; reduced rank regression; having at least 1 macronutrient outside the Acceptable Macronutrient Distribution Range (AMDR);2 or description of dietary pattern, including at a minimum, the foods and beverages included in pattern)3
Comparison Consumption of and/or adherence to a different dietary pattern, varying levels of adherence to a dietary pattern, or different macronutrient proportions
Outcome Intermediate markers of sarcopenia risk (i.e., skeletal muscle mass, muscle strength, muscle performance) and/or risk of sarcopenia or severe sarcopenia4
Study design Peer-reviewed controlled trials or observational trials (prospective cohort studies, retrospective cohort studies, nested case-control studies and case-control) published in English
1

Human development classification based on Human Development Index rank from the year the study intervention occurred, or data were collected. Available from http://hdr.undp.org/en/data. Rank higher than 110 indicative of medium or lower Human Development Index.

2

Outside AMDR: <45% or >65% of energy from carbohydrate, <20% or >35% of energy from fat, or <10% or >35% of energy from protein.

3

Interventions for weight loss or examining dietary supplements or single foods as a macronutrient source (i.e., nuts) were not included.

4

For detailed description of eligible outcome measures, see Supplemental Table 2.